These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1906903)

  • 1. Encainide and flecainide in children: separating the wheat from the chaff.
    Perry JC; Garson A
    J Am Coll Cardiol; 1991 Aug; 18(2):366-7. PubMed ID: 1906903
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs for cardiac arrhythmias: new warning.
    Med Lett Drugs Ther; 1989 May; 31(792):48. PubMed ID: 2497313
    [No Abstract]   [Full Text] [Related]  

  • 3. An interim perspective on the removal of encainide and flecainide from the cardiac arrhythmia suppression trial.
    Coyle JD; Schaal SF
    DICP; 1989 Jun; 23(6):478-9. PubMed ID: 2500783
    [No Abstract]   [Full Text] [Related]  

  • 4. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group.
    Fish FA; Gillette PC; Benson DW
    J Am Coll Cardiol; 1991 Aug; 18(2):356-65. PubMed ID: 1906902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of ventricular arrhythmias in children without structural heart disease with class IC agents as guided by invasive electrophysiology.
    Case CL; Gillette PC
    Am J Cardiol; 1990 Nov; 66(17):1265-6. PubMed ID: 2122708
    [No Abstract]   [Full Text] [Related]  

  • 6. Flecainide and CAST.
    Lancet; 1989 Aug; 2(8661):481-2. PubMed ID: 2570188
    [No Abstract]   [Full Text] [Related]  

  • 7. Lessons from the cardiac arrhythmia suppression trial.
    Garratt C; Ward DE; Camm AJ
    BMJ; 1989 Sep; 299(6703):805-6. PubMed ID: 2510839
    [No Abstract]   [Full Text] [Related]  

  • 8. Lessons to be learned from the cardiac arrhythmia suppression trial.
    Podrid PJ; Marcus FI
    Am J Cardiol; 1989 Nov; 64(18):1189-91. PubMed ID: 2510491
    [No Abstract]   [Full Text] [Related]  

  • 9. Recasting the approach to the treatment of potentially malignant ventricular arrhythmias after the CAST study.
    Bayés de Luna A; Guindo J; Borja J; Roman M; Madoery C
    Cardiovasc Drugs Ther; 1990 Jun; 4(3):651-5. PubMed ID: 2127537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late proarrhythmia and understanding the time of occurrence of proarrhythmia.
    Kennedy HL
    Am J Cardiol; 1990 Nov; 66(15):1139-43. PubMed ID: 2121018
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical use of class IC antiarrhythmic drugs.
    Abi Samra F
    J La State Med Soc; 1989 May; 141(5):27-31. PubMed ID: 2499646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Akhtar M; Breithardt G; Camm AJ; Coumel P; Janse MJ; Lazzara R; Myerburg RJ; Schwartz PJ; Waldo AL; Wellens HJ
    Circulation; 1990 Mar; 81(3):1123-7. PubMed ID: 1689621
    [No Abstract]   [Full Text] [Related]  

  • 13. The events surrounding the removal of encainide and flecainide from the Cardiac Arrhythmia Suppression Trial (CAST) and why CAST is continuing with moricizine.
    Bigger JT
    J Am Coll Cardiol; 1990 Jan; 15(1):243-5. PubMed ID: 2104884
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of antiarrhythmic agents in heart failure: implications of CAST.
    Gottlieb SS
    Am Heart J; 1989 Nov; 118(5 Pt 1):1074-7. PubMed ID: 2510486
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.
    Cardiac Arrhythmia Pilot Study (CAPS) Investigators
    Am J Cardiol; 1988 Mar; 61(8):501-9. PubMed ID: 2894169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encainide and flecainide: are they interchangeable?
    Saini V; Podrid PJ; Slater W; Lown B
    Am Heart J; 1989 Jun; 117(6):1253-8. PubMed ID: 2499169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAST and beyond. Implications of the cardiac arrhythmia suppression trials. By the Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Eur Heart J; 1990 Mar; 11(3):194-9. PubMed ID: 2108031
    [No Abstract]   [Full Text] [Related]  

  • 18. The cardiac arrhythmia suppression trial (CAST).
    Ruskin JN
    N Engl J Med; 1989 Aug; 321(6):386-8. PubMed ID: 2501683
    [No Abstract]   [Full Text] [Related]  

  • 19. Fact and fiction--results of the cardiac arrhythmia suppression trial.
    Wyse DG
    Can J Cardiol; 1991; 7(1):51-4; discussion 55-8. PubMed ID: 1902755
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for the development of proarrhythmic events.
    Morganroth J
    Am J Cardiol; 1987 Apr; 59(11):32E-37E. PubMed ID: 3107364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.